Clinical trial
Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients…
NCT00113841 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00113841 |
|---|---|
| Title | Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma |
| Official title | Pilot Study of Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Curcumin, Bioperine |
| Enrollment | 42 |
| Start date | Nov 1, 2004 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jun 13, 2005 |
| Last update posted | Nov 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: